Evidence map›Paper›PMID 32264791›Full record

ReviewCirculation research2020

Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2.

Mahmoud Gheblawi, Kaiming Wang, Anissa Viveiros, Quynh Nguyen, Jiu-Chang Zhong, Anthony J Turner, Mohan K Raizada, Maria B Grant, Gavin Y Oudit

2 registry-linked trialsOpen access · greenAbstract readReview
In one paragraph

Review in Circulation research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 1,177 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1,177citing papers in PubMed, 3 pooled it
41.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04489446 phase1 / phase2completednot on this map

Sildenafil for Treating Patients With COVID-19 and Perfusion Mismatch: A Pilot Randomised Trial

TypeinterventionalSponsorUniversidad Nacional Andres BelloRan2020 to 2021Enrolled40ConditionsCovid19, SARS-COV2 InfectionArmsSildenafil, Placebo
NCT04542213 phase3completednot on this map

Effect of the Combination of Dipeptidyl Peptidase-4 Inhibitor (DPP4i) and Insulin in Comparison to Insulin on Metabolic Control and Prognosis in Hospitalized Patients With COVID-19

TypeinterventionalSponsorHospital Regional de Alta Especialidad del BajioRan2020 to 2021Enrolled70ConditionsHyperglycemia, Covid19ArmsLinagliptin tablet, Insulin
3 · Its place in the literature

Who cites it

1,177 citing papers in PubMed, 3 syntheses or guidelines pooled it, 1,893 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Neuroprotective Potential of Peptide KSVSPKFLTG fromAntioxidants (Basel, Switzerland) · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. COVID-19 Prophylactic Effect of Bromhexine Hydrochloride.Immunity, inflammation and disease · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Observational
  20. Article

1,117 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 4 countries.

Mahmoud Gheblawi *From the Department of Physiology (M.G., A.V., G.Y.O.).
Kaiming Wang *Division of Cardiology, Department of Medicine, University of Alberta, Edmonton, Canada (K.W., Q.N., G.Y.O.).
Anissa ViveirosFrom the Department of Physiology (M.G., A.V., G.Y.O.).
Quynh NguyenDivision of Cardiology, Department of Medicine, University of Alberta, Edmonton, Canada (K.W., Q.N., G.Y.O.).
Jiu-Chang ZhongHeart Center and Beijing Key Laboratory of Hypertension, Beijing Chaoyang Hospital, Capital Medical University, China (J.-C.Z.).
Anthony J TurnerSchool of Biomedical Sciences, University of Leeds, United Kingdom (A.J.T.).
Mohan K RaizadaDepartment of Physiology and Functional Genomics, College of Medicine, University of Florida, Gainesville (M.K.R.).
Maria B GrantDepartment of Ophthalmology and Visual Sciences, University of Alabama at Birmingham (M.B.G.).
Gavin Y OuditFrom the Department of Physiology (M.G., A.V., G.Y.O.).
University of Alberta · CACapital Medical University · CNUniversity of Alabama at Birmingham · USUniversity of Florida · USUniversity of Leeds · GB

Funding

University of Alabama at Birmingham's Diabetes Research CenterP30DK079626 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BARBARA A GOWER · 2013 to 2026
$19.5M
Visual Phenotyping CoreP30EY003039 · NEI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Paul Douglas Gamlin · 1985 to 2026
$16.9M
Angiotensin-Converting Enzyme2 in Vascular Endothelial FunctionR01HL102033 · NHLBI · UNIVERSITY OF FLORIDA · PI RAIZADA, MOHAN K. · 2010 to 2019
$4.3M
Vascular Reparative Mechanism by ACE2/Ang-(1-7)in DiabetesR01HL110170 · NHLBI · UNIVERSITY OF FLORIDA · PI GRANT, MARIA BARTOLOMEO · 2011 to 2015
$2.2M
Somatostatin blockade of CNS autonomic hyperactivity for treatment of diabetic retinopathyR01EY028037 · NEI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BOULTON, MICHAEL EDWIN, FRAZIER, CHARLES J · 2017 to 2020
$1.9M
ACE2 Modulates the Bone Marrow- Gut Axis in Diabetic RetinopathyR01EY028858 · NEI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BOULTON, MICHAEL EDWIN, GRANT, MARIA BARTOLOMEO · 2018 to 2021
$1.6M
Canadian Institutes of HealthNEI NIH HHS P30 EY003039NEI NIH HHS R01 EY028037NEI NIH HHS R01 EY028858NHLBI NIH HHS R01 HL102033NHLBI NIH HHS R01 HL110170NIDDK NIH HHS P30 DK079626
6 · The paper itself

Abstract

ACE2 (angiotensin-converting enzyme 2) has a multiplicity of physiological roles that revolve around its trivalent function: a negative regulator of the renin-angiotensin system, facilitator of amino acid transport, and the severe acute respiratory syndrome-coronavirus (SARS-CoV) and SARS-CoV-2 receptor.

Indexed as

Cardiovascular DiseasesCoronavirus InfectionsPandemicsPneumonia, ViralADAM17 ProteinAngiotensin-Converting Enzyme 2AnimalsBetacoronavirusCOVID-19COVID-19 Drug TreatmentDiabetes ComplicationsHumansMolecular Targeted TherapyPeptidyl-Dipeptidase AReceptors, VirusRenin-Angiotensin SystemACE2 protein, humanADAM17 ProteinAngiotensin-Converting Enzyme 2Peptidyl-Dipeptidase AReceptors, Viruscardiovascular diseasescoronavirusdysbiosisheart failurerenin-angiotensin system

Identifiers

PMID32264791
PMCPMC7188049
OpenAlexW3014571869

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.